Translational Medicine and Therapeutics, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, Charterhouse Square, London EC1M 6BQ, UK.
PPAR Res. 2008;2008:904251. doi: 10.1155/2008/904251. Epub 2008 Nov 24.
The growth and metastasis of cancers intimately involve the vasculature and in particular the endothelial cell layer. Tumours require new blood vessel formation via angiogenesis to support growth. In addition, inflammation, coagulation, and platelet activation are common signals in the growth and metastasis of tumour cells. The endothelium plays a central role in the homeostatic control of inflammatory cell recruitment, regulating platelet activation and coagulation pathways. PPARalpha, -beta/delta, and -gamma are all expressed in endothelial cells. This review will discuss the roles of PPARs in endothelial cells in relation to angiogenesis, inflammation, coagulation, and platelet control pathways. In particular, we will discuss the recent evidence that supports the hypothesis that PPARalpha and PPARgamma are antiangiogenic receptors, while PPARbeta/delta is proangiogenic.
癌症的生长和转移与脉管系统密切相关,特别是内皮细胞层。肿瘤需要通过血管生成形成新的血管来支持生长。此外,炎症、凝血和血小板激活是肿瘤细胞生长和转移的常见信号。内皮细胞在炎症细胞募集的稳态控制中发挥核心作用,调节血小板激活和凝血途径。PPARα、β/δ和γ均在内皮细胞中表达。这篇综述将讨论 PPAR 在与血管生成、炎症、凝血和血小板控制途径相关的内皮细胞中的作用。特别是,我们将讨论支持 PPARα和 PPARγ是抗血管生成受体,而 PPARβ/δ是促血管生成的假设的最新证据。